IM Cannabis Corp. (IMCC) 10-Year Financial Performance & Capital Metrics

IMCC • • Industrial / General

HealthcareSpecialty & Generic PharmaCannabis & Hemp ProductsMedical Cannabis Producers

AboutIM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.Show more

Revenue $54M +10.7%
EBITDA -$8M +17.8%
Net Income -$11M -11.4%
EPS (Diluted) -4.51 -1.3%
Gross Margin 15.64% -22.5%
EBITDA Margin -14.9% +25.8%
Operating Margin -18.94% +27.7%
Net Margin -19.59% -0.7%
ROE -125.67% -148.1%
ROIC -33.4% -1.9%
Debt/Equity 5.73 +469.1%
Interest Coverage -2.29 +34.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 42.9%
✓Trading at only 1.0x book value
✓Efficient asset utilization: 1.4x turnover

✗Weaknesses

✗High debt to equity ratio of 5.7x
✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 14 (bottom 14%)
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y42.88%

3Y16.64%

TTM1.92%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM63.49%

EPS CAGR

10Y-

5Y-

3Y-

TTM79.52%

ROCE

10Y Avg-50.35%

5Y Avg-45.78%

3Y Avg-61.43%

Latest-101.14%

Peer Comparison

Medical Cannabis Producers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
ACBAurora Cannabis Inc.	239.88M	4.24	148.77	27.01%	7.68%	4.54%	0.17
IXHLIncannex Healthcare Limited	132.26M	0.38	-0.28	378.7%	-1671.96%	-466.4%	0.02
TLRYTilray Brands, Inc.	1.13B	9.71	-0.29	4.84%	-252.55%	-136.55%	0.22
IMCCIM Cannabis Corp.	7.08M	1.35	-0.30	10.71%	-8.96%	-109.13%	5.73
AKANAkanda Corp.	190.81K	1.31	-0.33	-61.27%	-12.14%	-8.5%	0.08
INCRInterCure Ltd.	52M	0.95	-0.67	-32.82%	-28.38%	-17.05%	0.53
FLGCFlora Growth Corp.	6.84M	6.54	-5.03	-21.78%	-32.14%	-24.58%	1.09

Profit & Loss

	Apr 2016	Apr 2017	Apr 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	4.39M	5.2M	9.07M	15.89M	34.05M	54.34M	48.8M	54.03M
Revenue Growth %	-	-	-	0.18%	0.75%	0.75%	1.14%	0.6%	-0.1%	0.11%
Cost of Goods Sold+	514	0	1.59M	999K	5.14M	5.42M	27.72M	45.17M	38.96M	45.58M
COGS % of Revenue	-	-	0.36%	0.19%	0.57%	0.34%	0.81%	0.83%	0.8%	0.84%
Gross Profit+	-514	0	2.8M	4.2M	3.93M	10.47M	6.33M	9.16M	9.85M	8.45M
Gross Margin %	-	-	0.64%	0.81%	0.43%	0.66%	0.19%	0.17%	0.2%	0.16%
Gross Profit Growth %	0.91%	1%	-	0.5%	-0.06%	1.66%	-0.4%	0.45%	0.07%	-0.14%
Operating Expenses+	44.47K	15.25K	1.81M	2.74M	14.2M	18.71M	29.37M	39.95M	22.64M	18.68M
OpEx % of Revenue	-	-	0.41%	0.53%	1.57%	1.18%	0.86%	0.74%	0.46%	0.35%
Selling, General & Admin	43.96K	15.25K	124.91K	3.03M	10.34M	18.71M	28.09M	28.91M	19.03M	13.28M
SG&A % of Revenue	-	-	0.03%	0.58%	1.14%	1.18%	0.82%	0.53%	0.39%	0.25%
Research & Development	0	0	0	83K	233K	136K	0	0	0	0
R&D % of Revenue	-	-	-	0.02%	0.03%	0.01%	-	-	-	-
Other Operating Expenses	514	0	1.68M	-369K	3.63M	-136K	1.27M	11.05M	3.61M	5.41M
Operating Income+	-44.47K	-15.25K	-125K	3.08M	-10.28M	-8.24M	-23.04M	-30.79M	-12.79M	-10.23M
Operating Margin %	-	-	-0.03%	0.59%	-1.13%	-0.52%	-0.68%	-0.57%	-0.26%	-0.19%
Operating Income Growth %	0.8%	0.66%	-7.2%	25.66%	-4.33%	0.2%	-1.79%	-0.34%	0.58%	0.2%
EBITDA+	-43.96K	7.57K	-44K	3.26M	-9.67M	-7.32M	-17.31M	-23.46M	-9.8M	-8.05M
EBITDA Margin %	-	-	-0.01%	0.63%	-1.07%	-0.46%	-0.51%	-0.43%	-0.2%	-0.15%
EBITDA Growth %	0.8%	1.17%	-6.82%	75.16%	-3.96%	0.24%	-1.37%	-0.36%	0.58%	0.18%
D&A (Non-Cash Add-back)	514	22.82K	81K	180K	601K	930K	5.73M	7.33M	3M	2.18M
EBIT	-45.11K	-15.25K	-125K	3.08M	-6.62M	-7.97M	509K	-24.09M	-5.79M	-8.33M
Net Interest Income+	0	0	26K	-84K	2.95M	-20.23M	22.87M	4.73M	3.33M	-2.56M
Interest Income	0	0	26K	84K	3.65M	277K	23.54M	6.7M	7.01M	1.91M
Interest Expense	500	500	0	0	707K	20.5M	673K	1.97M	3.67M	4.47M
Other Income/Expense	-1.14K	-500	-26K	285K	2.95M	-20.23M	22.87M	4.73M	3.33M	-2.56M
Pretax Income+	-45.61K	-15.75K	-125K	3.37M	-7.33M	-28.47M	-164K	-26.06M	-9.46M	-12.79M
Pretax Margin %	-	-	-0.03%	0.65%	-0.81%	-1.79%	-0%	-0.48%	-0.19%	-0.24%
Income Tax+	0	0	241K	741K	90K	262K	500K	-1.14M	771K	-1.02M
Effective Tax Rate %	1%	1%	-4.3%	0.5%	0.99%	1.01%	108.31%	7.25%	1%	0.83%
Net Income+	-45.61K	-15.75K	538K	1.68M	-7.29M	-28.7M	-17.76M	-188.89M	-9.5M	-10.59M
Net Margin %	-	-	0.12%	0.32%	-0.8%	-1.81%	-0.52%	-3.48%	-0.19%	-0.2%
Net Income Growth %	-0.21%	0.65%	35.16%	2.13%	-5.33%	-2.94%	0.38%	-9.63%	0.95%	-0.11%
Net Income (Continuing)	-45.61K	-15.75K	0	2.63M	-7.42M	-28.73M	-664K	-24.92M	-10.23M	-11.77M
Discontinued Operations	0	0	0	0	0	0	0	-166.38M	0	0
Minority Interest	-11.81M	-11.81M	-11.81M	1.43M	1.45M	1.51M	3.71M	1.15M	-769K	-2.1M
EPS (Diluted)+	-0.88	-0.30	-2.32	0.60	-13.80	-7.45	-3.00	-161.88	-4.45	-4.51
EPS Growth %	-0.21%	0.66%	-6.73%	1.26%	-24%	0.46%	0.6%	-52.96%	0.97%	-0.01%
EPS (Basic)	-0.88	-0.30	-2.32	0.60	-2.28	-7.45	-5.71	-76.80	-4.45	-4.51
Diluted Shares Outstanding	51.65K	51.65K	53.98K	2.82M	3.72M	3.86M	5.92M	1.15M	2.14M	2.35M
Basic Shares Outstanding	51.65K	51.65K	53.98K	2.82M	3.2M	3.86M	3.11M	2.46M	2.14M	2.35M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Apr 2016	Apr 2017	Apr 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	275	275	9.14K	37K	24.29M	27.14M	81.18M	32.67M	24.27M	23.36M
Cash & Short-Term Investments	170	170	4.03K	37K	13.93M	8.88M	13.9M	2.45M	1.81M	863K
Cash Only	170	170	4.03K	37K	13.93M	8.88M	13.9M	2.45M	1.81M	863K
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	105	105	5.12K	12.42K	2.06M	5.72M	31.18M	10.52M	11.33M	16.68M
Days Sales Outstanding	-	-	0.43	0.87	82.86	131.34	334.25	70.66	84.74	112.67
Inventory	0	0	0	0	5.47M	8.45M	31.08M	16.59M	9.98M	3.21M
Days Inventory Outstanding	-	-	-	-	388.34	568.71	409.22	134.01	93.47	25.75
Other Current Assets	0	0	0	-12.42K	0	235K	1K	0	0	64K
Total Non-Current Assets+	0	0	0	0	6.6M	10.97M	203.08M	28M	24.55M	15.82M
Property, Plant & Equipment	0	0	0	0	4.42M	6.47M	48.43M	7.15M	6.37M	4.18M
Fixed Asset Turnover	-	-	-	-	2.06x	2.46x	0.70x	7.60x	7.67x	12.92x
Goodwill	0	0	0	0	298K	304K	121.3M	9.77M	10.1M	6.68M
Intangible Assets	0	0	0	4K	889K	1.09M	30.89M	7.91M	5.8M	3.33M
Long-Term Investments	0	0	0	0	912K	2.34M	2.43M	2.41M	2.29M	1.63M
Other Non-Current Assets	0	0	0	-4K	0	0	14K	0	0	0
Total Assets+	276	276	9.14K	37K	30.89M	38.12M	287.39M	60.68M	48.81M	39.19M
Asset Turnover	-	-	480.48x	140.45x	0.29x	0.42x	0.12x	0.90x	1.00x	1.38x
Asset Growth %	-0.98%	0%	32.13%	3.05%	833.91%	0.23%	6.54%	-0.79%	-0.2%	-0.2%
Total Current Liabilities+	416.4K	432.15K	465.99K	251.65K	2.61M	6.27M	51.23M	33.82M	32.85M	34.92M
Accounts Payable	140.17K	145.42K	245.18K	238.91K	992K	2.6M	13.99M	15.31M	9.22M	11.16M
Days Payables Outstanding	99.54K	-	56.28	87.29	70.38	175.36	184.2	123.72	86.41	89.36
Short-Term Debt	5.94K	6.44K	0	0	0	0	9.5M	9.25M	12.12M	17.11M
Deferred Revenue (Current)	0	0	0	0	0	741K	137K	31K	787K	492K
Other Current Liabilities	0	0	0	0	1.23M	1.21M	8.27M	7.35M	3.74M	1.88M
Current Ratio	0.00x	0.00x	0.02x	0.15x	9.31x	4.33x	1.58x	0.97x	0.74x	0.67x
Quick Ratio	0.00x	0.00x	0.02x	0.15x	7.21x	2.98x	0.98x	0.48x	0.44x	0.58x
Cash Conversion Cycle	-	-	-	-	400.83	524.69	559.27	80.95	91.79	49.06
Total Non-Current Liabilities+	146.11K	151.86K	451K	0	2.18M	19.24M	31.22M	3.06M	2.31M	1.12M
Long-Term Debt	0	0	0	0	0	0	392K	399K	394K	466K
Capital Lease Obligations	0	0	0	0	891K	823K	17.82M	1.07M	815K	171K
Deferred Tax Liabilities	0	0	0	0	826K	1.5M	6.59M	1.33M	963K	487K
Other Non-Current Liabilities	0	0	451K	0	459K	16.91M	6.41M	254K	133K	487K
Total Liabilities	416.4K	432.15K	465.99K	251.65K	4.79M	25.51M	82.44M	36.88M	35.11M	36.04M
Total Debt+	5.94K	6.44K	0	0	1.05M	990K	29.27M	11.53M	13.78M	18.01M
Net Debt	5.77K	6.27K	-4.03K	-37K	-12.88M	-7.89M	15.37M	9.09M	11.97M	17.15M
Debt / Equity	-	-	-	-	0.04x	0.08x	0.14x	0.48x	1.01x	5.73x
Debt / EBITDA	-	0.85x	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	0.83x	-	-0.01x	-	-	-	-	-	-
Interest Coverage	-88.94x	-30.50x	-	-	-14.53x	-0.40x	-34.23x	-15.61x	-3.48x	-2.29x
Total Equity+	-416.12K	-431.87K	-456.84K	-214.65K	26.11M	12.61M	204.94M	23.8M	13.7M	3.15M
Equity Growth %	-0.12%	-0.04%	-0.06%	0.53%	122.64%	-0.52%	15.25%	-0.88%	-0.42%	-0.77%
Book Value per Share	-8.06	-8.36	-8.46	-0.08	7.02	3.27	34.62	20.71	6.41	1.34
Total Shareholders' Equity	11.39M	11.38M	11.35M	10.18M	24.66M	11.1M	201.24M	22.65M	14.47M	5.24M
Common Stock	26.23M	26.23M	26.33M	45K	25.95M	37.04M	237.68M	245.78M	253.88M	265M
Retained Earnings	-16.97M	-16.99M	-17.11M	-17.22M	-4.27M	-33M	-50.74M	-238.91M	-249.15M	-258.94M
Treasury Stock	0	0	0	0	0	0	-660K	0	0	0
Accumulated OCI	2.14M	2.14M	2.14M	43K	309K	1.23M	2.61M	16.45M	95K	-1.26M
Minority Interest	-11.81M	-11.81M	-11.81M	1.43M	1.45M	1.51M	3.71M	1.15M	-769K	-2.1M

Cash Flow

	Apr 2016	Apr 2017	Apr 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-26.6K	0	525K	-431K	-5.96M	-7.92M	-34.37M	-12.64M	-8.07M	-1.08M
Operating CF Margin %	-	-	0.12%	-0.08%	-0.66%	-0.5%	-1.01%	-0.23%	-0.17%	-0.02%
Operating CF Growth %	0.87%	1%	-	-1.82%	-12.83%	-0.33%	-3.34%	0.63%	0.36%	0.87%
Net Income	-45.61K	-15.75K	-20.43K	-122.67K	-7.42M	-28.73M	-18.52M	-191.3M	-10.23M	-11.77M
Depreciation & Amortization	514	0	81K	180K	601K	930K	5.73M	7.33M	3M	2.18M
Stock-Based Compensation	0	0	0	0	2.68M	3.38M	7.47M	3.77M	225K	369K
Deferred Taxes	0	0	0	0	-95K	-66K	278K	-3M	394K	-150K
Other Non-Cash Items	1.14K	500	435.61K	102.67K	919K	18.03M	-18.51M	136.09M	-2.87M	5.81M
Working Capital Changes	17.36K	15.25K	28.83K	-591K	-2.64M	-1.46M	-10.82M	34.48M	1.4M	2.48M
Change in Receivables	4.1K	0	-5.01K	-14K	-1.63M	-3.53M	-6.6M	6.06M	2.32M	-6.29M
Change in Inventory	0	0	80K	-1.3M	122K	-958K	-13.29M	1.45M	4.77M	6.26M
Change in Payables	0	0	59.01K	-4.28K	795K	2.13M	5.57M	11.28M	-6.1M	7.84M
Cash from Investing+	0	0	-426K	-729K	-3.77M	-4.08M	-9.01M	-1.41M	-1.18M	-470K
Capital Expenditures	0	0	-426K	-729K	-1.55M	-2.71M	-4.59M	-1.56M	-581K	-156K
CapEx % of Revenue	-	-	0.1%	0.14%	0.17%	0.17%	0.13%	0.03%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-2.23M	-18K	7.83M	560K	-601K	32K
Cash from Financing+	21.03K	0	100K	79.23K	17.05M	6.74M	48.73M	4.76M	9.42M	3.83M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	0	79.23K	2.43M	6.92M	13.43M	-2M	7.66M	4.43M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-26.6K	0	-522.14K	-775.25K	-7.51M	-10.63M	-38.97M	-14.2M	-8.66M	-1.23M
FCF Margin %	-	-	-0.12%	-0.15%	-0.83%	-0.67%	-1.14%	-0.26%	-0.18%	-0.02%
FCF Growth %	0.87%	1%	-	-0.48%	-8.68%	-0.42%	-2.67%	0.64%	0.39%	0.86%
FCF per Share	-0.51	-	-9.67	-0.28	-2.02	-2.76	-6.58	-12.36	-4.05	-0.52
FCF Conversion (FCF/Net Income)	0.58x	-	0.98x	-0.26x	0.82x	0.28x	1.94x	0.07x	0.85x	0.10x
Interest Paid	0	0	0	0	0	0	0	0	0	2.08M
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-	-56.32%	-148.24%	-16.33%	-165.16%	-50.66%	-125.67%
Return on Invested Capital (ROIC)	-	-	-	-	-118.73%	-68.91%	-15.35%	-18.24%	-32.77%	-33.4%
Gross Margin	-	-	63.81%	80.78%	43.3%	65.88%	18.6%	16.86%	20.17%	15.64%
Net Margin	-	-	12.25%	32.38%	-80.36%	-180.6%	-52.16%	-347.64%	-19.46%	-19.59%
Debt / Equity	-	-	-	-	0.04x	0.08x	0.14x	0.48x	1.01x	5.73x
Interest Coverage	-88.94x	-30.50x	-	-	-14.53x	-0.40x	-34.23x	-15.61x	-3.48x	-2.29x
FCF Conversion	0.58x	-	0.98x	-0.26x	0.82x	0.28x	1.94x	0.07x	0.85x	0.10x
Revenue Growth	-	-	-	18.3%	74.6%	75.12%	114.3%	59.56%	-10.18%	10.71%

Revenue by Segment

	2023	2024
Cannabis Products	-	51.35M
Cannabis Products Growth	-	-

Revenue by Geography

	2023	2024
ISRAEL	43.32M	-
ISRAEL Growth	-	-

Frequently Asked Questions

Growth & Financials

IM Cannabis Corp. (IMCC) reported $52.4M in revenue for fiscal year 2024.

IM Cannabis Corp. (IMCC) grew revenue by 10.7% over the past year. This is steady growth.

IM Cannabis Corp. (IMCC) reported a net loss of $4.7M for fiscal year 2024.

Dividend & Returns

IM Cannabis Corp. (IMCC) has a return on equity (ROE) of -125.7%. Negative ROE indicates the company is unprofitable.

IM Cannabis Corp. (IMCC) had negative free cash flow of $3.7M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

IM Cannabis Corp. (IMCC) 10-Year Financial Performance & Capital Metrics

IMCC • • Industrial / General

HealthcareSpecialty & Generic PharmaCannabis & Hemp ProductsMedical Cannabis Producers

Revenue $54M +10.7%
EBITDA -$8M +17.8%
Net Income -$11M -11.4%
EPS (Diluted) -4.51 -1.3%
Gross Margin 15.64% -22.5%
EBITDA Margin -14.9% +25.8%
Operating Margin -18.94% +27.7%
Net Margin -19.59% -0.7%
ROE -125.67% -148.1%
ROIC -33.4% -1.9%
Debt/Equity 5.73 +469.1%
Interest Coverage -2.29 +34.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 42.9%
✓Trading at only 1.0x book value
✓Efficient asset utilization: 1.4x turnover

✗Weaknesses

✗High debt to equity ratio of 5.7x
✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 14 (bottom 14%)
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y42.88%

3Y16.64%

TTM1.92%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM63.49%

EPS CAGR

10Y-

5Y-

3Y-

TTM79.52%

ROCE

10Y Avg-50.35%

5Y Avg-45.78%

3Y Avg-61.43%

Latest-101.14%

Peer Comparison

Medical Cannabis Producers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
ACBAurora Cannabis Inc.	239.88M	4.24	148.77	27.01%	7.68%	4.54%	0.17
IXHLIncannex Healthcare Limited	132.26M	0.38	-0.28	378.7%	-1671.96%	-466.4%	0.02
TLRYTilray Brands, Inc.	1.13B	9.71	-0.29	4.84%	-252.55%	-136.55%	0.22
IMCCIM Cannabis Corp.	7.08M	1.35	-0.30	10.71%	-8.96%	-109.13%	5.73
AKANAkanda Corp.	190.81K	1.31	-0.33	-61.27%	-12.14%	-8.5%	0.08
INCRInterCure Ltd.	52M	0.95	-0.67	-32.82%	-28.38%	-17.05%	0.53
FLGCFlora Growth Corp.	6.84M	6.54	-5.03	-21.78%	-32.14%	-24.58%	1.09

Profit & Loss

	Apr 2016	Apr 2017	Apr 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	4.39M	5.2M	9.07M	15.89M	34.05M	54.34M	48.8M	54.03M
Revenue Growth %	-	-	-	0.18%	0.75%	0.75%	1.14%	0.6%	-0.1%	0.11%
Cost of Goods Sold+	514	0	1.59M	999K	5.14M	5.42M	27.72M	45.17M	38.96M	45.58M
COGS % of Revenue	-	-	0.36%	0.19%	0.57%	0.34%	0.81%	0.83%	0.8%	0.84%
Gross Profit+	-514	0	2.8M	4.2M	3.93M	10.47M	6.33M	9.16M	9.85M	8.45M
Gross Margin %	-	-	0.64%	0.81%	0.43%	0.66%	0.19%	0.17%	0.2%	0.16%
Gross Profit Growth %	0.91%	1%	-	0.5%	-0.06%	1.66%	-0.4%	0.45%	0.07%	-0.14%
Operating Expenses+	44.47K	15.25K	1.81M	2.74M	14.2M	18.71M	29.37M	39.95M	22.64M	18.68M
OpEx % of Revenue	-	-	0.41%	0.53%	1.57%	1.18%	0.86%	0.74%	0.46%	0.35%
Selling, General & Admin	43.96K	15.25K	124.91K	3.03M	10.34M	18.71M	28.09M	28.91M	19.03M	13.28M
SG&A % of Revenue	-	-	0.03%	0.58%	1.14%	1.18%	0.82%	0.53%	0.39%	0.25%
Research & Development	0	0	0	83K	233K	136K	0	0	0	0
R&D % of Revenue	-	-	-	0.02%	0.03%	0.01%	-	-	-	-
Other Operating Expenses	514	0	1.68M	-369K	3.63M	-136K	1.27M	11.05M	3.61M	5.41M
Operating Income+	-44.47K	-15.25K	-125K	3.08M	-10.28M	-8.24M	-23.04M	-30.79M	-12.79M	-10.23M
Operating Margin %	-	-	-0.03%	0.59%	-1.13%	-0.52%	-0.68%	-0.57%	-0.26%	-0.19%
Operating Income Growth %	0.8%	0.66%	-7.2%	25.66%	-4.33%	0.2%	-1.79%	-0.34%	0.58%	0.2%
EBITDA+	-43.96K	7.57K	-44K	3.26M	-9.67M	-7.32M	-17.31M	-23.46M	-9.8M	-8.05M
EBITDA Margin %	-	-	-0.01%	0.63%	-1.07%	-0.46%	-0.51%	-0.43%	-0.2%	-0.15%
EBITDA Growth %	0.8%	1.17%	-6.82%	75.16%	-3.96%	0.24%	-1.37%	-0.36%	0.58%	0.18%
D&A (Non-Cash Add-back)	514	22.82K	81K	180K	601K	930K	5.73M	7.33M	3M	2.18M
EBIT	-45.11K	-15.25K	-125K	3.08M	-6.62M	-7.97M	509K	-24.09M	-5.79M	-8.33M
Net Interest Income+	0	0	26K	-84K	2.95M	-20.23M	22.87M	4.73M	3.33M	-2.56M
Interest Income	0	0	26K	84K	3.65M	277K	23.54M	6.7M	7.01M	1.91M
Interest Expense	500	500	0	0	707K	20.5M	673K	1.97M	3.67M	4.47M
Other Income/Expense	-1.14K	-500	-26K	285K	2.95M	-20.23M	22.87M	4.73M	3.33M	-2.56M
Pretax Income+	-45.61K	-15.75K	-125K	3.37M	-7.33M	-28.47M	-164K	-26.06M	-9.46M	-12.79M
Pretax Margin %	-	-	-0.03%	0.65%	-0.81%	-1.79%	-0%	-0.48%	-0.19%	-0.24%
Income Tax+	0	0	241K	741K	90K	262K	500K	-1.14M	771K	-1.02M
Effective Tax Rate %	1%	1%	-4.3%	0.5%	0.99%	1.01%	108.31%	7.25%	1%	0.83%
Net Income+	-45.61K	-15.75K	538K	1.68M	-7.29M	-28.7M	-17.76M	-188.89M	-9.5M	-10.59M
Net Margin %	-	-	0.12%	0.32%	-0.8%	-1.81%	-0.52%	-3.48%	-0.19%	-0.2%
Net Income Growth %	-0.21%	0.65%	35.16%	2.13%	-5.33%	-2.94%	0.38%	-9.63%	0.95%	-0.11%
Net Income (Continuing)	-45.61K	-15.75K	0	2.63M	-7.42M	-28.73M	-664K	-24.92M	-10.23M	-11.77M
Discontinued Operations	0	0	0	0	0	0	0	-166.38M	0	0
Minority Interest	-11.81M	-11.81M	-11.81M	1.43M	1.45M	1.51M	3.71M	1.15M	-769K	-2.1M
EPS (Diluted)+	-0.88	-0.30	-2.32	0.60	-13.80	-7.45	-3.00	-161.88	-4.45	-4.51
EPS Growth %	-0.21%	0.66%	-6.73%	1.26%	-24%	0.46%	0.6%	-52.96%	0.97%	-0.01%
EPS (Basic)	-0.88	-0.30	-2.32	0.60	-2.28	-7.45	-5.71	-76.80	-4.45	-4.51
Diluted Shares Outstanding	51.65K	51.65K	53.98K	2.82M	3.72M	3.86M	5.92M	1.15M	2.14M	2.35M
Basic Shares Outstanding	51.65K	51.65K	53.98K	2.82M	3.2M	3.86M	3.11M	2.46M	2.14M	2.35M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Apr 2016	Apr 2017	Apr 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	275	275	9.14K	37K	24.29M	27.14M	81.18M	32.67M	24.27M	23.36M
Cash & Short-Term Investments	170	170	4.03K	37K	13.93M	8.88M	13.9M	2.45M	1.81M	863K
Cash Only	170	170	4.03K	37K	13.93M	8.88M	13.9M	2.45M	1.81M	863K
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	105	105	5.12K	12.42K	2.06M	5.72M	31.18M	10.52M	11.33M	16.68M
Days Sales Outstanding	-	-	0.43	0.87	82.86	131.34	334.25	70.66	84.74	112.67
Inventory	0	0	0	0	5.47M	8.45M	31.08M	16.59M	9.98M	3.21M
Days Inventory Outstanding	-	-	-	-	388.34	568.71	409.22	134.01	93.47	25.75
Other Current Assets	0	0	0	-12.42K	0	235K	1K	0	0	64K
Total Non-Current Assets+	0	0	0	0	6.6M	10.97M	203.08M	28M	24.55M	15.82M
Property, Plant & Equipment	0	0	0	0	4.42M	6.47M	48.43M	7.15M	6.37M	4.18M
Fixed Asset Turnover	-	-	-	-	2.06x	2.46x	0.70x	7.60x	7.67x	12.92x
Goodwill	0	0	0	0	298K	304K	121.3M	9.77M	10.1M	6.68M
Intangible Assets	0	0	0	4K	889K	1.09M	30.89M	7.91M	5.8M	3.33M
Long-Term Investments	0	0	0	0	912K	2.34M	2.43M	2.41M	2.29M	1.63M
Other Non-Current Assets	0	0	0	-4K	0	0	14K	0	0	0
Total Assets+	276	276	9.14K	37K	30.89M	38.12M	287.39M	60.68M	48.81M	39.19M
Asset Turnover	-	-	480.48x	140.45x	0.29x	0.42x	0.12x	0.90x	1.00x	1.38x
Asset Growth %	-0.98%	0%	32.13%	3.05%	833.91%	0.23%	6.54%	-0.79%	-0.2%	-0.2%
Total Current Liabilities+	416.4K	432.15K	465.99K	251.65K	2.61M	6.27M	51.23M	33.82M	32.85M	34.92M
Accounts Payable	140.17K	145.42K	245.18K	238.91K	992K	2.6M	13.99M	15.31M	9.22M	11.16M
Days Payables Outstanding	99.54K	-	56.28	87.29	70.38	175.36	184.2	123.72	86.41	89.36
Short-Term Debt	5.94K	6.44K	0	0	0	0	9.5M	9.25M	12.12M	17.11M
Deferred Revenue (Current)	0	0	0	0	0	741K	137K	31K	787K	492K
Other Current Liabilities	0	0	0	0	1.23M	1.21M	8.27M	7.35M	3.74M	1.88M
Current Ratio	0.00x	0.00x	0.02x	0.15x	9.31x	4.33x	1.58x	0.97x	0.74x	0.67x
Quick Ratio	0.00x	0.00x	0.02x	0.15x	7.21x	2.98x	0.98x	0.48x	0.44x	0.58x
Cash Conversion Cycle	-	-	-	-	400.83	524.69	559.27	80.95	91.79	49.06
Total Non-Current Liabilities+	146.11K	151.86K	451K	0	2.18M	19.24M	31.22M	3.06M	2.31M	1.12M
Long-Term Debt	0	0	0	0	0	0	392K	399K	394K	466K
Capital Lease Obligations	0	0	0	0	891K	823K	17.82M	1.07M	815K	171K
Deferred Tax Liabilities	0	0	0	0	826K	1.5M	6.59M	1.33M	963K	487K
Other Non-Current Liabilities	0	0	451K	0	459K	16.91M	6.41M	254K	133K	487K
Total Liabilities	416.4K	432.15K	465.99K	251.65K	4.79M	25.51M	82.44M	36.88M	35.11M	36.04M
Total Debt+	5.94K	6.44K	0	0	1.05M	990K	29.27M	11.53M	13.78M	18.01M
Net Debt	5.77K	6.27K	-4.03K	-37K	-12.88M	-7.89M	15.37M	9.09M	11.97M	17.15M
Debt / Equity	-	-	-	-	0.04x	0.08x	0.14x	0.48x	1.01x	5.73x
Debt / EBITDA	-	0.85x	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	0.83x	-	-0.01x	-	-	-	-	-	-
Interest Coverage	-88.94x	-30.50x	-	-	-14.53x	-0.40x	-34.23x	-15.61x	-3.48x	-2.29x
Total Equity+	-416.12K	-431.87K	-456.84K	-214.65K	26.11M	12.61M	204.94M	23.8M	13.7M	3.15M
Equity Growth %	-0.12%	-0.04%	-0.06%	0.53%	122.64%	-0.52%	15.25%	-0.88%	-0.42%	-0.77%
Book Value per Share	-8.06	-8.36	-8.46	-0.08	7.02	3.27	34.62	20.71	6.41	1.34
Total Shareholders' Equity	11.39M	11.38M	11.35M	10.18M	24.66M	11.1M	201.24M	22.65M	14.47M	5.24M
Common Stock	26.23M	26.23M	26.33M	45K	25.95M	37.04M	237.68M	245.78M	253.88M	265M
Retained Earnings	-16.97M	-16.99M	-17.11M	-17.22M	-4.27M	-33M	-50.74M	-238.91M	-249.15M	-258.94M
Treasury Stock	0	0	0	0	0	0	-660K	0	0	0
Accumulated OCI	2.14M	2.14M	2.14M	43K	309K	1.23M	2.61M	16.45M	95K	-1.26M
Minority Interest	-11.81M	-11.81M	-11.81M	1.43M	1.45M	1.51M	3.71M	1.15M	-769K	-2.1M

Cash Flow

	Apr 2016	Apr 2017	Apr 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-26.6K	0	525K	-431K	-5.96M	-7.92M	-34.37M	-12.64M	-8.07M	-1.08M
Operating CF Margin %	-	-	0.12%	-0.08%	-0.66%	-0.5%	-1.01%	-0.23%	-0.17%	-0.02%
Operating CF Growth %	0.87%	1%	-	-1.82%	-12.83%	-0.33%	-3.34%	0.63%	0.36%	0.87%
Net Income	-45.61K	-15.75K	-20.43K	-122.67K	-7.42M	-28.73M	-18.52M	-191.3M	-10.23M	-11.77M
Depreciation & Amortization	514	0	81K	180K	601K	930K	5.73M	7.33M	3M	2.18M
Stock-Based Compensation	0	0	0	0	2.68M	3.38M	7.47M	3.77M	225K	369K
Deferred Taxes	0	0	0	0	-95K	-66K	278K	-3M	394K	-150K
Other Non-Cash Items	1.14K	500	435.61K	102.67K	919K	18.03M	-18.51M	136.09M	-2.87M	5.81M
Working Capital Changes	17.36K	15.25K	28.83K	-591K	-2.64M	-1.46M	-10.82M	34.48M	1.4M	2.48M
Change in Receivables	4.1K	0	-5.01K	-14K	-1.63M	-3.53M	-6.6M	6.06M	2.32M	-6.29M
Change in Inventory	0	0	80K	-1.3M	122K	-958K	-13.29M	1.45M	4.77M	6.26M
Change in Payables	0	0	59.01K	-4.28K	795K	2.13M	5.57M	11.28M	-6.1M	7.84M
Cash from Investing+	0	0	-426K	-729K	-3.77M	-4.08M	-9.01M	-1.41M	-1.18M	-470K
Capital Expenditures	0	0	-426K	-729K	-1.55M	-2.71M	-4.59M	-1.56M	-581K	-156K
CapEx % of Revenue	-	-	0.1%	0.14%	0.17%	0.17%	0.13%	0.03%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-2.23M	-18K	7.83M	560K	-601K	32K
Cash from Financing+	21.03K	0	100K	79.23K	17.05M	6.74M	48.73M	4.76M	9.42M	3.83M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	0	79.23K	2.43M	6.92M	13.43M	-2M	7.66M	4.43M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-26.6K	0	-522.14K	-775.25K	-7.51M	-10.63M	-38.97M	-14.2M	-8.66M	-1.23M
FCF Margin %	-	-	-0.12%	-0.15%	-0.83%	-0.67%	-1.14%	-0.26%	-0.18%	-0.02%
FCF Growth %	0.87%	1%	-	-0.48%	-8.68%	-0.42%	-2.67%	0.64%	0.39%	0.86%
FCF per Share	-0.51	-	-9.67	-0.28	-2.02	-2.76	-6.58	-12.36	-4.05	-0.52
FCF Conversion (FCF/Net Income)	0.58x	-	0.98x	-0.26x	0.82x	0.28x	1.94x	0.07x	0.85x	0.10x
Interest Paid	0	0	0	0	0	0	0	0	0	2.08M
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-	-56.32%	-148.24%	-16.33%	-165.16%	-50.66%	-125.67%
Return on Invested Capital (ROIC)	-	-	-	-	-118.73%	-68.91%	-15.35%	-18.24%	-32.77%	-33.4%
Gross Margin	-	-	63.81%	80.78%	43.3%	65.88%	18.6%	16.86%	20.17%	15.64%
Net Margin	-	-	12.25%	32.38%	-80.36%	-180.6%	-52.16%	-347.64%	-19.46%	-19.59%
Debt / Equity	-	-	-	-	0.04x	0.08x	0.14x	0.48x	1.01x	5.73x
Interest Coverage	-88.94x	-30.50x	-	-	-14.53x	-0.40x	-34.23x	-15.61x	-3.48x	-2.29x
FCF Conversion	0.58x	-	0.98x	-0.26x	0.82x	0.28x	1.94x	0.07x	0.85x	0.10x
Revenue Growth	-	-	-	18.3%	74.6%	75.12%	114.3%	59.56%	-10.18%	10.71%

Revenue by Segment

	2023	2024
Cannabis Products	-	51.35M
Cannabis Products Growth	-	-

Revenue by Geography

	2023	2024
ISRAEL	43.32M	-
ISRAEL Growth	-	-

Frequently Asked Questions

Growth & Financials

IM Cannabis Corp. (IMCC) reported $52.4M in revenue for fiscal year 2024.

IM Cannabis Corp. (IMCC) grew revenue by 10.7% over the past year. This is steady growth.

IM Cannabis Corp. (IMCC) reported a net loss of $4.7M for fiscal year 2024.

Dividend & Returns

IM Cannabis Corp. (IMCC) has a return on equity (ROE) of -125.7%. Negative ROE indicates the company is unprofitable.

IM Cannabis Corp. (IMCC) had negative free cash flow of $3.7M in fiscal year 2024, likely due to heavy capital investments.